Friday 6 November 2026 Export RXST’s income statement to Excel — free account

RxSight, Inc.

RXST Healthcare Medical Devices

RxSight, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $134.5 million, down 3.89% from fiscal 2024.

Revenue: −19.0%
EPS: −62.1%
Free cash flow: +2,591.1%

Quarter to September 2026, against a year earlier

Operating cash flow growth 3 yrs

4.57 0.03 +0.66%

Follow RXST

Alert me

Market cap: $190.4M
P/E: 0.0×
Fwd P/E: −5.2×
Dividend yield: —
F-score: 3/9
Altman Z: 5.03
Beneish M: −3.15
Dividend safety: n/a

Overview

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
P/E ratio Full definition →	+8 more quarters Free account	0.00	0.00	0.00	0.00
P/S ratio Full definition →		3.17	2.00	1.57	1.68
P/FCF ratio Full definition →		0.00	0.00	0.00	10.96
P/Operating CF Full definition →		(381.42)	(23.36)	(20.97)	4.52
P/B ratio Full definition →		1.54	0.95	0.76	0.80
Price to Tangible BV Full definition →		1.54	0.95	0.76	0.80
EV/Sales Full definition →		1.61	0.44	0.08	(0.25)
EV/EBITDA Full definition →		0.00	0.00	0.00	0.47
EV/Operating CF Full definition →		(14.00)	(3.20)	(0.47)	(1.30)
EV/FCF Full definition →		(11.23)	(2.60)	(0.40)	(1.65)
Quick Ratio Full definition →		9.58	8.78	3.57	3.62
Current Ratio Full definition →		10.95	10.20	4.07	4.20
Net Debt/EBITDA Full definition →		18.52	11.56	14.38	13.20
Debt/Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →		0.00	0.00	0.00	0.00
Asset Turnover Full definition →		0.43	0.41	0.39	0.38
Operating CF/Net income Full definition →		0.12	0.69	0.79	(2.79)
Capex/Depreciation Full definition →		1.16	0.74	2.60	1.52
Interest Coverage Full definition →		(2,834.00)	(5,943.00)	(4,590.00)	(6,172.67)
Research and Development Expense of Revenue Full definition →		27.31%	30.66%	27.38%	37.47%
Selling, General and Administrative Expense of Revenue Full definition →		84.93%	103.11%	90.15%	111.46%
Intangible Assets out of Total Assets Full definition →		0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →		23.97%	25.72%	22.12%	31.05%
Graham Net Nets Full definition →		0.59	0.95	1.19	1.12
Graham Number Full definition →		0.00	0.00	0.00	0.00
Earnings Yield Full definition →		(9.12%)	(18.34%)	(23.44%)	(26.10%)
Free Cash Flow Yield Full definition →		(4.54%)	(8.48%)	(13.58%)	9.12%
Revenue per Share Full definition →		0.80	0.75	0.81	0.59
Operating CF per Share Full definition →		(0.03)	(0.26)	(0.23)	1.08
Capex per Share Full definition →		(0.03)	(0.02)	(0.05)	(0.03)
Free Cash Flow per Share Full definition →		(0.06)	(0.28)	(0.28)	1.06
Cash per Share Full definition →		5.58	5.27	5.03	6.11
Shareholders Equity per Share Full definition →		6.75	6.47	6.35	6.11
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		6.75	6.47	6.35	6.11
Free Cash Flow Full definition →		(2.25)	(11.65)	(11.49)	44.04
Working Capital Full definition →		261.21	251.85	246.95	239.85
Capital Expenditures Full definition →		(1.14)	(0.76)	(1.96)	(1.17)
Net Current Asset Value Full definition →		251.33	242.53	238.04	229.30
EV/EBIT Full definition →		0.00	0.00	0.00	0.50
Capex to Sales Full definition →		0.03	0.02	0.06	0.05
Price to Operating Income Full definition →		0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →		26.72	26.70	53.29	20.57
Average Payables Full definition →		4.92	7.12	4.85	3.40
Average Inventory Full definition →		26.78	29.22	31.09	34.27
Average Assets Full definition →		315.19	308.52	330.85	324.48
Average Common Equity Full definition →		278.46	273.31	270.68	265.44

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly